Jazz Pharmaceuticals JAZZ Sales return reserve
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:SalesReturnReserveCurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's sales return reserve.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Jazz Pharmaceuticals's sales return reserve?
- Jazz Pharmaceuticals (JAZZ) reported sales return reserve of $26.6M in Q1 2026.
- How has Jazz Pharmaceuticals's sales return reserve changed year-over-year?
- Jazz Pharmaceuticals's sales return reserve decreased by 5.4% year-over-year, from $28.13M to $26.6M.
- What is the long-term trend for Jazz Pharmaceuticals's sales return reserve?
- Over 3 years (2022 to 2025), Jazz Pharmaceuticals's sales return reserve has grown at a 0.3% compound annual growth rate (CAGR), from $26.16M to $26.4M.